arrow
D

David G. Menter

university of texas m d anderson cancer center
H指数:51
被引数:8,519

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC program

结直肠癌的癌症进化概况和拦截框架: ASCEND-CRC计划

2026-01-080
PRE
Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer

Ⅰ/Ⅱ期临床试验:encorafenib、cetuximab和nivolumab在微卫星稳定型BRAFV600E转移性结直肠癌中的应用

2025-08-280
OAAI
Anti-CSF1R antibody monotherapy inhibits minimal residual disease in a novel immunocompetent murine colorectal cancer metastasis model
2024-03-220
PRE
YAP-TAZ-TEAD transcriptional program is a prominent driver of acquired resistance to KRASG12C-based therapies in patients with metastatic colorectal cancer
2024-03-220
PRE
Recapitulating metastatic colorectal cancer in somatic mutation models for investigating the tumor immune microenvironment in minimal residual disease
2023-04-040
PRE